Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucy Bailey

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Pharmacological and Toxicological Methods|January 3, 2013
A simple whole blood bioassay detects cytokine responses to anti-CD28SA and anti-CD52 antibodiesLucy Bailey, Laura Moreno, Tobias Manigold, et al.
The British Journal of Dermatology|November 15, 2025
Indeterminate Dendritic Cell Histiocytosis Harboring ETV3::NCOA2 Translocation with Complete Metabolic Response to MEK InhibitionVyshnavi Rallapalle, Jennifer Toral-Orduno, Brinda Shukla, et al.
Trials|October 3, 2020
The MUK eight protocol: a randomised phase II trial of cyclophosphamide and dexamethasone in combination with ixazomib, in relapsed or refractory multiple myeloma (RRMM) patients who have relapsed after treatment with thalidomide, lenalidomide and a proteasome inhibitorSamantha Hinsley, Katrina Walker, Debbie Sherratt, et al.
British Journal of Haematology|February 18, 2026
Systemic Xanthogranuloma or Erdheim-Chester disease: A systematic review re-examining the classification challengeVyshnavi Rallapalle, Sailesh I S Kumar, Brinda Shukla, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Pharmacological and Toxicological Methods|January 3, 2013
A simple whole blood bioassay detects cytokine responses to anti-CD28SA and anti-CD52 antibodiesLucy Bailey, Laura Moreno, Tobias Manigold, et al.
The British Journal of Dermatology|November 15, 2025
Indeterminate Dendritic Cell Histiocytosis Harboring ETV3::NCOA2 Translocation with Complete Metabolic Response to MEK InhibitionVyshnavi Rallapalle, Jennifer Toral-Orduno, Brinda Shukla, et al.
Trials|October 3, 2020
The MUK eight protocol: a randomised phase II trial of cyclophosphamide and dexamethasone in combination with ixazomib, in relapsed or refractory multiple myeloma (RRMM) patients who have relapsed after treatment with thalidomide, lenalidomide and a proteasome inhibitorSamantha Hinsley, Katrina Walker, Debbie Sherratt, et al.
British Journal of Haematology|February 18, 2026
Systemic Xanthogranuloma or Erdheim-Chester disease: A systematic review re-examining the classification challengeVyshnavi Rallapalle, Sailesh I S Kumar, Brinda Shukla, et al.
Pageof 2